This session will review the latest developments in prostate cancer treatments and trends in clinical trials, assessing how these developments may potentially impact the racial disparity in prostate cancer. It will also examine active prostate cancer clinical trials to understand future treatment trends and outline existing opportunities for patients to participate in these trials.
Agenda:
Watch Video Welcome: Artie Shelton, MD, COL (ret) U.S. Army, PHEN Ambassador
Watch Video Opening Remarks and Moderator: Keith Crawford, MD, PhD, Director of Clinical Trials and Patient Education, PHEN
Watch Video Review of New Treatments and Trends: Richard Lee, MD, PhD, Clinical Co-Director: Claire and John Bertucci Center for Genitourinary Cancers at Mass General Cancer Center, Assistant Professor, Harvard Medical School
Watch Video Where Are Clinical Trials Leading Us? Alicia K. Morgans, MD, Director of Adult Survivorship, Associate Professor of Medicine, Dana-Farber Cancer Institute, Harvard Medical School
Watch Video Reviewing Emerging Clinical Trials: Keith Crawford, MD, PhD, and David Vasir, PhD, Senior Research Analyst, PHEN
Watch Video Patient Clinical Trial Stories:
- Mr. Sherman Womack, Prostate Cancer Survivor
- Mr. Charles “Chuck” Christian, Prostate Cancer Survivor
- Mr. Art Cain, Prostate Cancer Survivor
Watch Video Closing Remarks and Survey: Mr. Thomas A. Farrington
SPONSORS
PHEN thanks its sponsors for their support of the 2025 Summit.
